BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26802236)

  • 1. Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.
    Tsuchisaka A; Numata S; Teye K; Natsuaki Y; Kawakami T; Takeda Y; Wang W; Ishikawa K; Goto M; Koga H; Sogame R; Ishii N; Takamori S; Hoshino T; Brandt O; Pas HH; Fujiwara S; Hashimoto T
    J Invest Dermatol; 2016 Feb; 136(2):399-408. PubMed ID: 26802236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
    Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extremities of the N-terminus of envoplakin and C-terminus of its linker subdomain are major epitopes of paraneoplastic pemphigus.
    Wang X; Chen T; Zhao J; Peng Y; Chen X; Tu P; Zhu X; Liu Z; Wang M
    J Dermatol Sci; 2016 Oct; 84(1):24-29. PubMed ID: 27427435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis.
    Hashimoto T; Amagai M; Watanabe K; Chorzelski TP; Bhogal BS; Black MM; Stevens HP; Boorsma DM; Korman NJ; Gamou S
    J Invest Dermatol; 1995 May; 104(5):829-34. PubMed ID: 7738363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
    Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
    J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-α-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus.
    Numata S; Teye K; Tsuruta D; Sogame R; Ishii N; Koga H; Natsuaki Y; Tsuchisaka A; Hamada T; Karashima T; Nakama T; Furumura M; Ohata C; Kawakami T; Schepens I; Borradori L; Hashimoto T
    J Invest Dermatol; 2013 Jul; 133(7):1785-93. PubMed ID: 23407400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis Obliterans With Anti-Epiplakin Antibodies in a Boy With Paraneoplastic Pemphigus.
    Rivas-Calderon M; Yamazaki-Nakashimada MA; Orozco-Covarrubias L; Durán-McKinster C; Pacheco-Tovar D; Ávalos-Díaz E; Sáez-de-Ocariz M
    Pediatrics; 2022 Mar; 149(3):. PubMed ID: 35118492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus.
    Hashimoto T; Amagai M; Ning W; Nishikawa T; Karashima T; Mori O; Jablonska S; Chorzelski TP
    J Dermatol Sci; 1998 Jun; 17(2):132-9. PubMed ID: 9673895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic pemphigus associated with bronchiolitis obliterans.
    Takahashi M; Shimatsu Y; Kazama T; Kimura K; Otsuka T; Hashimoto T
    Chest; 2000 Feb; 117(2):603-7. PubMed ID: 10669715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and appearance of anti-BP180 antibodies in the late stage of the disease.
    Kanaoka M; Matsukura S; Ishikawa H; Matsuura M; Ishii N; Hashimoto T; Aihara M
    J Dermatol; 2014 Jul; 41(7):628-30. PubMed ID: 24985544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin.
    Mahoney MG; Aho S; Uitto J; Stanley JR
    J Invest Dermatol; 1998 Aug; 111(2):308-13. PubMed ID: 9699735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus.
    Hasegawa Y; Shimokata K; Ichiyama S; Saito H
    Eur Respir J; 1999 Apr; 13(4):934-7. PubMed ID: 10362065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases.
    Ota T; Amagai M; Watanabe M; Nishikawa T
    J Dermatol Sci; 2003 Aug; 32(2):137-41. PubMed ID: 12850306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
    Li J; Bu DF; Huang YC; Zhu XJ
    Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic pemphigus.
    Zhu X; Zhang B
    J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies against alpha-2-macroglobulin-like 1 in paraneoplastic pemphigus sera utilizing novel green fluorescent protein-based immunoassays.
    Bazzini C; Begré N; Favre B; Hashimoto T; Hertl M; Schlapbach C; Borradori L
    J Dermatol Sci; 2020 Jun; 98(3):173-178. PubMed ID: 32439251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic pemphigus in association with Castleman's disease.
    Nikolskaia OV; Nousari CH; Anhalt GJ
    Br J Dermatol; 2003 Dec; 149(6):1143-51. PubMed ID: 14674890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus.
    Proby C; Fujii Y; Owaribe K; Nishikawa T; Amagai M
    J Invest Dermatol; 1999 Feb; 112(2):153-6. PubMed ID: 9989789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.
    Inaoki M; Kodera M; Fujimoto A; Nousari HC; Anhalt GJ; Takehara K
    Br J Dermatol; 2001 Mar; 144(3):610-3. PubMed ID: 11260026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
    Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
    J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.